According to a US cost analysis, inpatient candidaemia treatment is "extremely costly"

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1565, 2006-01, pp. : 5-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment for diabetic leg ulcers costly in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 464, 2004-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

Anidulafungin cost effective for candidaemia and candidiasis

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 580, 2009-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite

Resource Utilization and Cost of Treatment with Anidulafungin or Fluconazole for Candidaemia and Other Forms of Invasive Candidiasis: Focus on Critically Ill Patients

By Reboli Annette C.

PharmacoEconomics, Vol. 29, Iss. 8, 2011-08 ,pp. : 705-717

Adis International

Access to resources Recommend Favorite

Febrile neutropenia costly in the US

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 661, 2012-01 ,pp. : 8-8

Adis International

Access to resources Recommend Favorite

GORD costly to US employers

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 540, 2007-01 ,pp. : 13-13

Adis International

Access to resources Recommend Favorite